Recently added to this list, is the investigation of plasma IGF-1R in cancer patients (32): anti-IGF-1R antibodies sequestered by circulating IGF-1R in the plasma could diminish any proposed therapeutic effect on cancer cells (Figure 2). Here, IGF1R is linked to cancer.